Health Outcomes Research in Medicine
Volume 2, Issue 4 , Pages e203-e214 , November 2011

The Burden of Fibromyalgia: Assessment of Health Status Using the EuroQol (EQ-5D) in Patients with Fibromyalgia Relative to Other Chronic Conditions

  • Xuemei Luo, PhD

      Affiliations

    • Global Health Economics & Outcomes Research, Pfizer Inc., New London, Conn
    • Corresponding Author InformationCorresponding Author: Xuemei Luo, PhD, Pfizer Inc., 50 Pequot Avenue, New London, CT 06320.
  • ,
  • Joseph C. Cappelleri, PhD, MPH, MS

      Affiliations

    • Global Research and Development, Pfizer Inc., New London, Conn
  • ,
  • Arthi Chandran, MS, MPH

      Affiliations

    • Global Health Economics & Outcomes Research, Pfizer Inc., New York, NY

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 The research reported in this article was funded by Pfizer Inc. Xuemei Luo, Joseph C. Cappelleri, and Arthi Chandran are all employees and stockholders of Pfizer, Inc., the sponsor of this study.

PII: S1877-1319(11)00027-9

doi: 10.1016/j.ehrm.2011.08.002

Health Outcomes Research in Medicine
Volume 2, Issue 4 , Pages e203-e214 , November 2011